Crowgey, Erin L.
Marsh, Adam G.
Robinson, Karyn G.
Yeager, Stephanie K.
Akins, Robert E. http://orcid.org/0000-0001-9706-0752
Funding for this research was provided by:
Delaware Bioscience Center for Advanced Technology (Pilot Grant Award)
American Academy for Cerebral Palsy and Developmental Medicine (Pedal with Pete Foundation Award)
Delaware CTR ACCEL Program (U54-GM104941)
National Science Foundation (0944557, 1316055)
Swank Foundation (Unnumbered Award)
Article History
Received: 13 January 2018
Accepted: 29 May 2018
First Online: 21 June 2018
Ethics approval and consent to participate
: Twenty-two subjects with a diagnosis of spastic CP and 21 control subjects were enrolled in this IRB-approved study at the Nemours - Alfred I. duPont Hospital for Children after written informed parental consent and subject assent. Approval for the study and the assent and consent documents was provided by Nemours Institutional Review Board 1, which has full accreditation from the Association for the Accreditation of Human Research Protection Programs and operates under the Federal Wide Assurance identification number FWA00000293.
: The technology and software platform used to assess DNA methylation patterns were developed by Adam Marsh in his capacity as a professor of Computational Biology and Bioinformatics at the University of Delaware. The intellectual property is licensed by Genome Profiling LLC from the University. Author Adam Marsh declares a financial interest in Genome Profiling LLC.Authors Erin Crowgey, Karyn Robinson, Stephanie Yeager, and Robert Akins have no competing interests.